Medical Care Technologies Inc. (OTC PINK:MDCE) Approved as Official Apple Developer
Medical Care Technologies (OTC PINK:MDCE) announced it was approved as an Apple Developer on October 24, 2025, enabling the company to create, test, and distribute iOS apps worldwide.
The company said its first AI-based mobile application (Name Pending Trademark) is in final development and is planned for release in Q4 2025. Management framed the approval as a key step to expand digital health and AI offerings to iPhone and iPad users.
Medical Care Technologies (OTC PINK:MDCE) ha annunciato di essere stata approvata come Apple Developer il 24 ottobre 2025, permettendo all'azienda di creare, testare e distribuire app iOS in tutto il mondo.
L'azienda ha detto che la sua prima applicazione mobile basata sull'IA (Nome in attesa di marchio) è in fase di sviluppo finale e sarà rilasciata nel Q4 2025. La direzione ha inquadrato l'approvazione come un passo chiave per espandere le offerte di salute digitale e IA agli utenti di iPhone e iPad.
Medical Care Technologies (OTC PINK:MDCE) anunció que fue aprobada como Apple Developer el 24 de octubre de 2025, lo que permite a la empresa crear, probar y distribuir aplicaciones iOS en todo el mundo.
La empresa indicó que su primera aplicación móvil basada en IA (Nombre en trámite de marca) está en desarrollo final y se espera su lanzamiento en Q4 2025. La dirección enmarcó la aprobación como un paso clave para ampliar las ofertas de salud digital e IA a los usuarios de iPhone y iPad.
Medical Care Technologies (OTC PINK:MDCE)가 2025년 10월 24일 Apple Developer로 승인되어 회사가 전 세계적으로 iOS 앱을 생성, 테스트 및 배포할 수 있게 되었다고 발표했습니다.
회사는 첫 번째 AI 기반 모바일 애플리케이션(상표명 대기 중)이 최종 개발 단계에 있으며 2025년 4분기에 출시될 예정이라고 밝혔습니다. 경영진은 이 승인을 디지털 헬스 및 AI 제공을 아이폰과 아이패드 사용자에게 확장하는 중요한 단계로 규정했습니다.
Medical Care Technologies (OTC PINK:MDCE) a annoncé avoir été approuvée en tant que Apple Developer le 24 octobre 2025, ce qui permet à l'entreprise de créer, tester et distribuer des applications iOS dans le monde entier.
L'entreprise a déclaré que sa première application mobile basée sur l'IA (Nom soumis à marque) est en développement final et est prévue pour sortir au Q4 2025. La direction a présenté cette approbation comme une étape clé pour étendre les offres de santé numérique et d'IA aux utilisateurs d'iPhone et d'iPad.
Medical Care Technologies (OTC PINK:MDCE) gab bekannt, dass es am 24. Oktober 2025 als Apple Developer genehmigt wurde, was dem Unternehmen ermöglicht, weltweit iOS-Apps zu erstellen, zu testen und zu verteilen.
Das Unternehmen sagte, dass seine erste KI-basierte mobile Anwendung (Name pending Trademark) in der Endentwicklung ist und voraussichtlich im Q4 2025 veröffentlicht wird. Die Geschäftsführung sah die Zulassung als wichtigen Schritt, um digitale Gesundheit und KI-Angebote für Benutzer von iPhone und iPad zu erweitern.
Medical Care Technologies (OTC PINK:MDCE) أعلنت أنها تمت المصادقة عليها كـ مطوّر أبل في 24 أكتوبر 2025، مما يمكّن الشركة من إنشاء تطبيقات iOS واختبارها ونشرها في جميع أنحاء العالم.
وقالت الشركة إن أول تطبيق جوّال قائم على الذكاء الاصطناعي (اسم العلامة التجارية قيد الانتظار) في مراحل التطوير النهائية ومن المخطط إصداره في الربع الرابع 2025. وصفت الإدارة هذه المصادقة بأنها خطوة رئيسية لتوسيع عروض الصحة الرقمية والذكاء الاصطناعي لمستخدمي iPhone و iPad.
Medical Care Technologies (OTC PINK:MDCE) 宣布已获批为 Apple Developer，于 2025 年 10 月 24 日授权，使公司能够在全球范围内创建、测试和分发 iOS 应用。
公司表示，其第一款基于 AI 的移动应用（商标名待定）正处于最终开发阶段，计划在 2025 年第四季度发布。管理层将这次批准视为向 iPhone 与 iPad 用户扩展数字健康与 AI 产品的关键一步。
- None.
- None.
Company advances digital technology initiatives with approval to publish applications on Apple's App Store
MESA, ARIZONA / ACCESS Newswire / October 24, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE), a technology-driven company specializing in innovative digital health and AI applications, today announced that it has been formally approved as an Apple Developer. This approval enables the company to create, test, and distribute mobile applications for iOS users worldwide.
"Becoming an approved Apple Developer represents a key step in our mission to introduce accessible and intelligent technology to consumers," said [Marshall Perkins, CEO]. "Our team is excited to expand our digital capabilities and bring new, user-focused experiences to iPhone and iPad users sooner than expected."
The company's first AI-based application, (Name Pending Trademark), is currently in its final development stage and will be available in Q4.
About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTC PINK:MDCE), headquartered in Mesa, Arizona, is a technology company focused on digital health innovation and consumer applications utilizing artificial intelligence and smart imaging.
Visit us at www.medicalcaretechnologies.com
Safe Harbor Statement:
This press release contains forward-looking statements that are subject to risks and uncertainties. Actual results may differ materially from those described. All statements other than statements of historical fact are forward-looking and involve known and unknown risks, uncertainties, and other factors. Medical Care Technologies Inc. assumes no obligation to update these forward-looking statements.
Contact:
Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com
Source: Medical Care Technologies Inc. (OTC PINK:MDCE)
View the original press release on ACCESS Newswire
FAQ
What does Medical Care Technologies (MDCE) Apple Developer approval mean for users?
When will MDCE's first AI-based app be available on the App Store?
How does the October 24, 2025 Apple Developer approval affect MDCE's digital strategy?
Will MDCE's new app be available globally on Apple's App Store?
Who commented on the Apple Developer approval for MDCE on October 24, 2025?
